Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03365882
Title S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Southwest Oncology Group

rectum adenocarcinoma

colon adenocarcinoma


Cetuximab + Irinotecan

Pertuzumab + Trastuzumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST